NYSE - Delayed Quote USD

Taro Pharmaceutical Industries Ltd. (TARO)

42.40 -0.08 (-0.19%)
At close: April 26 at 4:00 PM EDT
42.40 0.00 (0.00%)
After hours: April 26 at 5:16 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
610,828.00
572,952.00
561,347.00
548,970.00
Cost of Revenue
317,553.00
304,629.00
268,225.00
252,314.00
Gross Profit
293,275.00
268,323.00
293,122.00
296,656.00
Operating Expense
271,300.00
250,609.00
168,217.00
151,507.00
Operating Income
21,975.00
17,714.00
124,905.00
145,149.00
Net Non Operating Interest Income Expense
48,394.00
20,850.00
8,187.00
20,174.00
Other Income Expense
3,970.00
-351.00
-55,234.00
-556,396.00
Pretax Income
74,340.00
38,213.00
77,858.00
-391,073.00
Tax Provision
28,638.00
12,768.00
19,592.00
9,667.00
Net Income Common Stockholders
45,702.00
25,445.00
58,266.00
-386,653.00
Diluted NI Available to Com Stockholders
45,702.00
25,445.00
58,266.00
-386,653.00
Basic EPS
1.22
0.68
1.55
-10.12
Diluted EPS
1.22
0.68
1.55
-10.12
Basic Average Shares
37,585.00
37,585.00
37,641.00
38,210.00
Diluted Average Shares
37,585.00
37,585.00
37,641.00
38,210.00
Total Operating Income as Reported
21,975.00
17,714.00
63,459.00
-413,775.00
Total Expenses
588,853.00
555,238.00
436,442.00
403,821.00
Net Income from Continuing & Discontinued Operation
45,702.00
25,445.00
58,266.00
-386,653.00
Normalized Income
45,623.31
27,318.46
102,742.83
21,627.97
Interest Income
49,647.00
22,103.00
9,840.00
21,537.00
Interest Expense
3,039.00
1,253.00
1,653.00
1,363.00
Net Interest Income
48,394.00
20,850.00
8,187.00
20,174.00
EBIT
43,727.00
39,466.00
79,511.00
-389,710.00
EBITDA
77,406.00
71,593.00
105,426.00
-366,030.00
Reconciled Cost of Revenue
317,553.00
304,629.00
268,225.00
252,314.00
Reconciled Depreciation
33,679.00
32,127.00
25,915.00
23,680.00
Net Income from Continuing Operation Net Minority Interest
45,702.00
25,445.00
58,266.00
-386,653.00
Total Unusual Items Excluding Goodwill
128.00
-2,813.00
-59,461.00
-559,289.00
Total Unusual Items
128.00
-2,813.00
-59,461.00
-559,289.00
Normalized EBITDA
77,278.00
74,406.00
164,887.00
193,259.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
49.31
-939.54
-14,984.17
-151,008.03
3/31/2021 - 9/14/1982

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PBH Prestige Consumer Healthcare Inc.
70.47
+0.47%
 
KMDA Kamada Ltd.
5.15
-0.96%
 
IRWD Ironwood Pharmaceuticals, Inc.
7.82
-3.22%
 
LFCR Lifecore Biomedical, Inc.
6.60
-0.68%
 
KLAR.ST Klaria Pharma Holding AB (publ.)
0.3290
+7.87%
 
SPR.CN Sproutly Canada Inc.
0.0200
0.00%
 
LVRLF CordovaCann Corp.
0.0890
0.00%
 
COLL Collegium Pharmaceutical, Inc.
36.42
+1.62%
 
PCRX Pacira BioSciences, Inc.
26.33
+3.25%
 
INDV Indivior PLC
17.58
+1.91%